FTDI
First Trust Direct Indexing’s Elevance Health ELV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-10,313
| Closed | -$5.36M | – | 280 |
|
|
2024
Q3 | $5.36M | Buy |
10,313
+530
| +5% | +$276K | 0.29% | 61 |
|
|
2024
Q2 | $5.3M | Buy |
9,783
+1,516
| +18% | +$821K | 0.33% | 50 |
|
|
2024
Q1 | $4.29M | Buy |
8,267
+545
| +7% | +$283K | 0.32% | 55 |
|
|
2023
Q4 | $3.64M | Buy |
7,722
+1,876
| +32% | +$885K | 0.33% | 51 |
|
|
2023
Q3 | $2.55M | Buy |
5,846
+254
| +5% | +$111K | 0.29% | 62 |
|
|
2023
Q2 | $2.48M | Sell |
5,592
-395
| -7% | -$176K | 0.28% | 66 |
|
|
2023
Q1 | $2.75M | Sell |
5,987
-18
| -0.3% | -$8.28K | 0.33% | 52 |
|
|
2022
Q4 | $3.08M | Sell |
6,005
-348
| -5% | -$179K | 0.41% | 39 |
|
|
2022
Q3 | $2.89M | Sell |
6,353
-7
| -0.1% | -$3.18K | 0.42% | 38 |
|
|
2022
Q2 | $3.07M | Buy |
6,360
+319
| +5% | +$154K | 0.43% | 40 |
|
|
2022
Q1 | $2.97M | Buy |
6,041
+329
| +6% | +$162K | 0.36% | 47 |
|
|
2021
Q4 | $2.65M | Sell |
5,712
-232
| -4% | -$108K | 0.34% | 53 |
|
|
2021
Q3 | $2.22M | Buy |
5,944
+399
| +7% | +$149K | 0.32% | 57 |
|
|
2021
Q2 | $2.12M | Buy |
5,545
+1,839
| +50% | +$702K | 0.32% | 59 |
|
|
2021
Q1 | $1.33M | Buy |
3,706
+170
| +5% | +$61K | 0.35% | 60 |
|
|
2020
Q4 | $1.14M | Buy |
+3,536
| New | +$1.14M | 0.31% | 60 |
|